Hearing Loss clinical trials at UCLA

2 in progress, 1 open to eligible people

Showing trials for

  • DB-OTO, an AAV Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations

    open to eligible people ages up to 17 years

    This is a first-in-human, multicenter, Phase 1/2, open-label, 2-part trial with a single-ascending dose patient cohort (Part A) and a bilateral expansion patient cohort (Part B) to evaluate the safety, tolerability, and preliminary efficacy of DB-OTO, an AAV based gene therapy in pediatric patients with biallelic OTOF mutations

    Los Angeles, California and other locations

  • Cochlear Implant With Dexamethasone Eluting Electrode Array

    Sorry, in progress, not accepting new patients

    An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.

    Los Angeles, California and other locations

Our lead scientists for Hearing Loss research studies include .

Last updated: